Computed Tomography (CT) in Head and Neck Patients
This study has been terminated.
(insufficient recruitment)
Sponsor:
University Health Network, Toronto
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00188656
First received: September 12, 2005
Last updated: December 14, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.
| Condition | Intervention | Phase |
|---|---|---|
|
Lung Tumors |
Procedure: CT thorax |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer |
Resource links provided by NLM:
Further study details as provided by University Health Network, Toronto:
Primary Outcome Measures:
- Detection of lung metastases
| Estimated Enrollment: | 100 |
| Study Start Date: | August 2003 |
| Estimated Study Completion Date: | September 2006 |
A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma
Eligibility| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients with squamous cell carcinoma of the head and neck
Exclusion Criteria:
- None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00188656
Locations
| Canada, Ontario | |
| Princess Margaret Hospital | |
| Toronto, Ontario, Canada | |
Sponsors and Collaborators
University Health Network, Toronto
Investigators
| Principal Investigator: | Narinder Paul, FRCP C | University Health Network, Toronto |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00188656 History of Changes |
| Other Study ID Numbers: | 03-0467 |
| Study First Received: | September 12, 2005 |
| Last Updated: | December 14, 2010 |
| Health Authority: | Canada: Health Canada |
Additional relevant MeSH terms:
|
Head and Neck Neoplasms Lung Neoplasms Neoplasms by Site Neoplasms |
Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013